Prothena Corp. (PRTA)
20.56
0.00 (0.00%)
Upcoming Events
Latest Headlines
Prothena (PRTA) Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
April 15, 2024 4:06 PM - StreetInsider
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
April 15, 2024 4:05 PM - BizWire
Form ARS PROTHENA CORP PUBLIC For: Dec 31
March 29, 2024 5:07 PM - SEC Filing
Form DEFA14A PROTHENA CORP PUBLIC
March 29, 2024 5:06 PM - SEC Filing
Form DEF 14A PROTHENA CORP PUBLIC For: May 14
March 29, 2024 5:03 PM - SEC Filing
Form 4 PROTHENA CORP PUBLIC For: Mar 01 Filed by: Ford David A
March 5, 2024 9:03 PM - SEC Filing
Form 3 PROTHENA CORP PUBLIC For: Mar 01 Filed by: Ford David A
March 5, 2024 9:02 PM - SEC Filing
Prothena to Participate in Upcoming Healthcare Conferences
March 5, 2024 4:05 PM - BizWire
Prothena Appoints David Ford to Newly Created Chief People Officer Position
March 4, 2024 4:05 PM - BizWire
Form 4 PROTHENA CORP PUBLIC For: Feb 27 Filed by: Zago Wagner M.
February 29, 2024 9:13 PM - SEC Filing
Form 4 PROTHENA CORP PUBLIC For: Feb 27 Filed by: Walker Karin L
February 29, 2024 9:11 PM - SEC Filing
Form 4 PROTHENA CORP PUBLIC For: Feb 27 Filed by: Smith Brandon S.
February 29, 2024 9:11 PM - SEC Filing
Form 4 PROTHENA CORP PUBLIC For: Feb 27 Filed by: Nguyen Tran
February 29, 2024 9:10 PM - SEC Filing
Form 4 PROTHENA CORP PUBLIC For: Feb 27 Filed by: Malecek Michael J
February 29, 2024 9:08 PM - SEC Filing
Form 4 PROTHENA CORP PUBLIC For: Feb 27 Filed by: Kinney Gene G.
February 29, 2024 9:05 PM - SEC Filing
Form 4 PROTHENA CORP PUBLIC For: Feb 27 Filed by: Karp Carol D.
February 29, 2024 9:04 PM - SEC Filing
Form 4 PROTHENA CORP PUBLIC For: Feb 27 Filed by: Garren Hideki
February 29, 2024 9:03 PM - SEC Filing
Form 4 PROTHENA CORP PUBLIC For: Feb 21 Filed by: WELCH DANIEL G
February 23, 2024 5:40 PM - SEC Filing
Form 3 PROTHENA CORP PUBLIC For: Feb 21 Filed by: WELCH DANIEL G
February 23, 2024 5:38 PM - SEC Filing
Prothena Corp. (PRTA) Announces Share Offering
February 22, 2024 7:43 PM - StreetInsider
Form S-3ASR PROTHENA CORP PUBLIC
February 22, 2024 5:30 PM - SEC Filing
Form 10-K PROTHENA CORP PUBLIC For: Dec 31
February 22, 2024 4:57 PM - SEC Filing
Form 8-K PROTHENA CORP PUBLIC For: Feb 21
February 21, 2024 4:07 PM - SEC Filing
Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate
February 21, 2024 4:05 PM - BizWire
Prothena Corp (PRTA) PT Lowered to $80 at Oppenheimer
February 20, 2024 7:43 AM - StreetInsider
Prothena Corp (PRTA) PT Raised to $85 at JMP Securities
February 16, 2024 3:01 AM - StreetInsider
Prothena Corp. (PRTA) Misses Q4 EPS by 8c
February 15, 2024 4:23 PM - StreetInsider
Form 8-K PROTHENA CORP PUBLIC For: Feb 15
February 15, 2024 4:10 PM - SEC Filing
Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights
February 15, 2024 4:05 PM - BizWire
Form SC 13G PROTHENA CORP PUBLIC Filed by: Fennell Todd W.
February 14, 2024 12:17 PM - SEC Filing
Form SC 13G PROTHENA CORP PUBLIC Filed by: SCULLY WILLIAM P
February 14, 2024 10:52 AM - SEC Filing
Form SC 13G/A PROTHENA CORP PUBLIC Filed by: PRICE T ROWE ASSOCIATES INC /MD/
February 14, 2024 10:04 AM - SEC Filing
Form SC 13G/A PROTHENA CORP PUBLIC Filed by: Avidity Partners Management LP
February 13, 2024 7:49 PM - SEC Filing
Form SC 13G/A PROTHENA CORP PUBLIC Filed by: FMR LLC
February 9, 2024 9:50 AM - SEC Filing
Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
February 8, 2024 4:05 PM - BizWire
Form SC 13G/A PROTHENA CORP PUBLIC Filed by: BlackRock Inc.
February 2, 2024 2:19 PM - SEC Filing
BofA Securities Downgrades Prothena Corp (PRTA) to Neutral
January 30, 2024 6:04 AM - StreetInsider
Full Article List
